AI Summary
Thinking
Thinking
We reviewed 3 live results for rna exome sequencing and narrowed them down to the 3 options that look most worth comparing first.
The options are Exome Sequencing, TruSeq RNA Exome and Exome Sequencing.
Source: CeGaT GmbH
Description
CeGaT GmbH provides comprehensive Whole Exome Sequencing (WES) services, sequencing protein-coding genomic regions using Illumina paired-end platforms and Twist Bioscience target enrichment. Processed in an accredited laboratory in Tübingen, Germany, the service supports research in rare diseases, oncology, and population genetics across human and mouse samples. Deliverables include structured project reports, FASTQ data, and scalable bioinformatic analysis levels utilizing the Illumina DRAGEN Bio-IT Platform with standard turnaround times of 15 days.
Best for
researchers, physicians, rare disease research and tumor profiling
Rate this product
Source: Illumina
Description
TruSeq RNA Exome, formerly known as the TruSeq RNA Access Library Prep Kit, is an Illumina sequencing library preparation and enrichment solution. It provides an economical, reproducible workflow for sequencing human coding RNA from degraded or low-input samples, including formalin-fixed paraffin-embedded (FFPE) tissues. Utilizing biotinylated capture probes targeting coding RNA without requiring poly-A tails, the kit enables stranded transcriptome analysis, novel transcript discovery, and gene fusion detection from as little as 10 ng total RNA.
Best for
Genomics researchers, Molecular biology laboratories, Sequencing RNA from FFPE tissue samples and Low-input human coding transcriptome analysis
Rate this product
Source: MGZ
Description
MGZ offers exome sequencing diagnostic services, including Clinical Exome and Whole Exome testing, using next-generation sequencing to identify disease-causing genetic variants. Designed for patients with suspected hereditary diseases or rare disorders where standard gene panels fail to yield a diagnosis, testing is available in single and trio analysis formats with turnaround times of 8 to 12 weeks.
Best for
patients with suspected hereditary diseases, individuals with undiagnosed rare genetic disorders, cases where phenotype-based gene panels are inconclusive and first-line testing for heterogeneous conditions
Rate this product
| Compare | #1Exome Sequencing | #2TruSeq RNA Exome | #3Exome Sequencing |
|---|---|---|---|
| Source | CeGaT GmbH | Illumina | MGZ |
| Description | CeGaT GmbH provides comprehensive Whole Exome Sequencing (WES) services, sequencing protein-coding genomic regions using Illumina paired-end platforms and Twist Bioscience target enrichment. Processed in an accredited laboratory in Tübingen, Germany, the service supports research in rare diseases, oncology, and population genetics across human and mouse samples. Deliverables include structured project reports, FASTQ data, and scalable bioinformatic analysis levels utilizing the Illumina DRAGEN Bio-IT Platform with standard turnaround times of 15 days. | TruSeq RNA Exome, formerly known as the TruSeq RNA Access Library Prep Kit, is an Illumina sequencing library preparation and enrichment solution. It provides an economical, reproducible workflow for sequencing human coding RNA from degraded or low-input samples, including formalin-fixed paraffin-embedded (FFPE) tissues. Utilizing biotinylated capture probes targeting coding RNA without requiring poly-A tails, the kit enables stranded transcriptome analysis, novel transcript discovery, and gene fusion detection from as little as 10 ng total RNA. | MGZ offers exome sequencing diagnostic services, including Clinical Exome and Whole Exome testing, using next-generation sequencing to identify disease-causing genetic variants. Designed for patients with suspected hereditary diseases or rare disorders where standard gene panels fail to yield a diagnosis, testing is available in single and trio analysis formats with turnaround times of 8 to 12 weeks. |
| Best for | researchers, physicians, rare disease research and tumor profiling | Genomics researchers, Molecular biology laboratories, Sequencing RNA from FFPE tissue samples and Low-input human coding transcriptome analysis | patients with suspected hereditary diseases, individuals with undiagnosed rare genetic disorders, cases where phenotype-based gene panels are inconclusive and first-line testing for heterogeneous conditions |
| Action | CeGaT GmbH | Illumina | |
| Rate this product |
"Exome Sequencing from CeGaT GmbH."
Note: TopFind AI compiles product and service information for general comparison purposes only.